Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nurel is a Spanish chemical and textile company, part of the Samca Group, that has established a significant presence in the life sciences sector through its Nurel Biopolymers division. Founded in 1968 and headquartered in Zaragoza, the company specializes in the production of synthetic fibers and engineering plastics, notably Nylon 6 and 6.6. Its biopolymer brand, Inzea, focuses on developing biodegradable and compostable materials for applications in sustainable packaging, agriculture, and medical-grade plastics, positioning Nurel as a key player in the transition to bio-based materials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nurel.